Y., et al., Nature, 376, 509-514 (1995).
2. Wang, S.L, and Strittmatter, S.M. J. Neurosci., 16,
6197-6207 (1996).
3. Nakamura, F., et al., J. Neurobiol., 44, 219-229
(2000).
4. Deo, R.C., et al
Tetrahedron Lett. 3333, 1589.
2. M. Mutter et al. (1995) Pept. Res. 88, 145.
3. P. White et al. (2004) J. Pept. Sci. 1100, 18.
4. N. Schmiedeberg & H. Kessler (2002) Org. Lett. 44, 59.
5. R. von Eggelkraut-
Y. et al., Nature, 376, 509-514 (1995).
2. Wang, S.L, and Strittmatter, S.M., J. Neurosci., 16,
6197-6207 (1996).
3. Nakamura, F. et al., J. Neurobiol., 44, 219-229
(2000).
4. Deo, R.C. et al
in Aqueous Solutions. J. Indian Chem. Soc., 62, 507-512
(1985).
4. P. Gariglio, Useful for rupturing eukaryote cells in transcription studies FEBS Lett. 44, 330
(1974)
5. R.J. MacDonald, In the
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) is available with identical media formulation in different filling
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) is available with identical media formulation in different filling
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) is available with identical media formulation in different filling
Y., et al., Nature, 376, 509-514 (1995).
2. Wang, S.L, and Strittmatter, S.M. J. Neurosci., 16,
6197-6207 (1996).
3. Nakamura, F., et al., J. Neurobiol., 44, 219-229
(2000).
4. Deo, R.C., et al
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) w. Chloramphenicol is available with identical media formulation
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Sabouraud Dextrose Agar (SDA) w. Chloramphenicol is available with identical media formulation
MacConkey
agar number (%)
Positive for coliforms 71 (88.75) 62 (87)
False positive 7 (8.75) 9 (13)
False negative 2 (2.5) ND
Following preliminary identification on their respective media
MacConkey
agar number (%)
Positive for coliforms 71 (88.75) 62 (87)
False positive 7 (8.75) 9 (13)
False negative 2 (2.5) ND
Following preliminary identification on their respective media
130 x 500 mm VS 180 x 500 mm VS 250 x 500 mm
Tube internal diameter (mm) 62 89 127 178 252
Cross-sectional area (cm2) 31 62 125 250 500
Adjustable bed height (mm) 0–480 0–465
channel.,
Neuron, 7, 35-44 (1991).
2. Dubel, S.J., et al., Molecular cloning of the α-1
subunit of an ω-conotoxin-sensitive calcium
channel., Proc. Natl. Acad. Sci. USA, 89,
5058-62 (1992).
3. Hell
protein containing 67 amino
acids and shares similar structural features with IGF-I,
including a 62% sequence homology.
7
In human
plasma, IGF-I and IGF-II are associated with
IGF-binding proteins
J. Science 216:696-703.
Neville D. M. & Youle R. (1982). J. Immunol. Review 62:75.
Barclay A. N. (1981). Immunol. 44:727-736.
Barclay A. N. & Mayrhofer G. (1981). J. Exp. Med. 153:1666-1671.
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Tryptic Soy Agar (TSA) is available with identical media formulation in different filling volumes
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Tryptic Soy Agar (TSA) is available with identical media formulation in different filling volumes
the current European, Japanese and United States Pharmacopoeia (EP, 2.6.13.;
JP, 4.05 and USP, 62).
Tryptic Soy Agar (TSA) is available with identical media formulation in different filling volumes